Ipsen S.A. (IPSEF)
OTCMKTS · Delayed Price · Currency is USD
113.13
+9.63 (9.30%)
At close: Jun 9, 2025
Ipsen Market Cap
Ipsen has a market cap or net worth of $11.28 billion as of August 22, 2025. Its market cap has increased by 16.40% in one year.
Market Cap
11.28B
Enterprise Value
10.71B
Revenue
4.42B
Ranking
n/a
PE Ratio
21.45
Stock Price
$113.13
Market Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 2.08B to 11.28B, an increase of 441.82%. That is a compound annual growth rate of 8.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 11.28B | 19.02% |
| Dec 31, 2024 | 9.48B | -3.79% |
| Dec 29, 2023 | 9.85B | 11.34% |
| Dec 30, 2022 | 8.85B | 17.52% |
| Dec 31, 2021 | 7.53B | 9.75% |
| Dec 31, 2020 | 6.86B | -6.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 610.45M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |